World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: TCTR
Last refreshed on: 29 April 2024
Main ID:  TCTR20141127002
Date of registration: 27/11/2014
Prospective Registration: No
Primary sponsor: Faculty of Medicine Chulalongkorn University
Public title: Hypertensive Phase and Its Association with Surgical Failure in Baerveldt Implantation
Scientific title: Hypertensive Phase and Its Association with Surgical Failure in Baerveldt Implantation
Date of first enrolment: 19/12/2013
Target sample size:
Recruitment status: Completed
URL:  https://www.thaiclinicaltrials.org/show/TCTR20141127002
Study type:  Observational
Study design:  N/A  
Phase:  N/A
Countries of recruitment
Contacts
Name: Department of Ophthalmology Faculty of Medicine   Chulalongkorn university
Address:  Rama4 road, Patumwan Bangkok Thailand
Telephone: 022564142
Email: tammapat@gmail.com
Affiliation:  Chulalongkorn university
Name: SUPAWAN    SURUKRATTANASKUL
Address:  162 Puengmee21, Sukumvit road, Banggak Phrakanong 10260 Bangkok Thailand
Telephone: 0851656117
Email: lim_auddy@yahoo.com
Affiliation:  Faculty of Medicine Chulalongkorn university
Key inclusion & exclusion criteria
Inclusion criteria: • Glaucoma patients age ≥20 yrs who need surgical treatment by Baerveldt implantation
• Baerveldt implantation by glaucoma specialist in King Chulalongkorn Memorial Hospital since 2004 to present and follow up >=18 months

Exclusion criteria: • Glaucoma patients operated by Baerveldt combined with other procedure such as Trabeculectomy with antimetabolites
• Patient F/U less than 18 months


Age minimum: 20 Years
Age maximum: 80 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Hypertensive Phase Baerveldt implantation
Rate of hypertensive phase and its association with surgical failure
Hypertensive Phase Baerveldt implantation
Intervention(s)
Baerveldt implantation patients
Glaucoma patients, age > 20 years, with indication for Baerveldt implant, operated in King Chulalongkorn Memorial Hospital since 2004-2014.
Treatment
Primary Outcome(s)
Rate of hypertensive phase 18 months Percent
Secondary Outcome(s)
Surgical failure 18 months Percent
Secondary ID(s)
Source(s) of Monetary Support
Department of Ophthalmology
Secondary Sponsor(s)
King Chulalongkorn Memorial Hospital
Ethics review
Status: Submitted, approved
Approval date:
Contact:
http://research.md.chula.ac.th
Institutional Review Board
662 256 4493 Ext. 14,15
http://research.md.chula.ac.th
Results
Results available:
Date Posted:
Date Completed: 24/11/2014
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history